International Conference on
Central Nervous System - Drug Effects & Novel Drug Development
September 5-7, 2012 DoubleTree by Hilton Philadelphia, USA
Central Nervous System-2012

    Previous Events
    Participants List in Academia
    Untitled Document
    University of Texas at Arlington, USA

    Stanford University School of Medicine, USA

    Mahidol University, Thailand

    Amirkabir University of Technology, Iran

    Hamdard University, India

    Yeshiva University, USA

    University of Macau, China

    Monash University, Australia

    University of Michigan, Ann Arbor

    University Federal do Rio de Janeiro, Brazil

    University of Denver, Colorado

    University of Toronto, Canada

    Zagazig University, Egypt

    Banaras Hindu University, India

    Taipei Medical University, Taiwan

    University di Messina CNISM, Italy

    University of Tasmania, Australia

    Huazhong University of Science and Technology, China

    Sogang University, Korea

    University of Edinburgh, UK

    Martin-Luther-University Halle-Wittenberg, USA

    University de Sao Paulo, Brazil

    Eve University, Turkey

    University of Delhi, India

    Isfahan University of Technology(IUT), Iran

    Taif University, Saudi Arabia

    University Medical Center, Netherlands

    University of Copenhagen, Denmark

    University Paris 13, France

    Participants List From Business
    Untitled Document
    Cadila Pharmaceuticals, India

    Chemical Works of Gedeon Richter, Hungary

    3S-Pharmacological Consultation & Research GmbH, Germany

    Royal Brisbane and Womens Hospital, Australia

    Psoriasis and Cutaneous Inflammation Research Laboratory, USA

    Alcon Laboratories Inc., USA

    National Institute for Materials Science (NIMS), Japan

    Grup de Recerca de Reumatologia (IRHVH), Spain

    Bayer Health Care, Richmond, USA

    Crown Bioscience Inc., China

    Hammersmith Hospital, London

    Van Drie Research LLC, USA

    Dr.Reddys labs, India

    Merck Research Laboratories, USA

    National Institute of Pharmaceutical Education and Research (NIPER), India

    AstraZeneca R&D Boston, USA

    Abbott Laboratories, USA

    Hutchison MediPharma Limited, China

    Sage Bionetworks, USA

    Central Drug Research Institute, India

    Glenmark Pharmaceuticals, India

    National Institute for Interdisciplinary Science & Technology (NIIST) , India

    Novartis Campus, Austria

    Upcoming Conferences
    Day 1
    Scientific Program
    International Conference on Central Nervous System-Drug Effects & Novel Drug Development, will be organized around the theme "Novel Therapeutic Approaches in Control of CNS Disorders."

    Central Nervous System-2012 is comprised of 13 tracks and 68 sessions designed to offer comprehensive sessions that address current issues in Central Nervous System.

    Submit your abstract to any of the following tracks.

    Register now for the conference by choosing an appropriate package suitable to you.
    Abstract Submission   Register
    Track 1: Drug Discovery and Development in Neurosciences
    Track 1-1 Neuropharmacology, ADME/T in drug discovery
    Track 1-2 Anti-neurodegenerative drug discovery
    Track 1-3 Ion channels, transporters and neurotransmitter receptors
    Track 1-4 Neural stem cells and gene or cell therapy
    Track 1-5 Neurotransmitters, neuromodulators, and neuroreceptors
    Track 1-6 Centrally acting analgesics
    Track 2: Drug Metabolism in Drug Design
    Track 2-1 Blood brain barrier (BBB)
    Track 2-2 Metabolism mediated drug-drug interactions
    Track 2-3 Enzyme kinetics
    Track 2-4 Role of drug metabolism in drug development
    Track 2-5 Nanoparticles as drug carriers
    Track 3: Clinical Trials on CNS
    Track 3-1 Clinical development in MS, PD and AD
    Track 3-2 Biomarkers implication in clinical trials
    Track 3-3 Schizophrenia and depression
    Track 3-4 Current challenges in translational CNS research
    Track 3-5 Facilitating and establishing industry and academic partnering
    Track 4: Neurological Drug Targets
    Track 4-1 Properties of drug molecules
    Track 4-2 Therapeutic target discovery
    Track 4-3 Target validation
    Track 4-4 Lead optimization
    Track 4-5 Drug delivery systems
    Track 5: Disorders Related to CNS
    Track 5-1 Acoustic neuroma
    Track 5-2 Encephalitis
    Track 5-3 Juvenile huntington disease
    Track 5-4 Spinal meningitis
    Track 5-5 Motor neuron disease
    Track 5-6 Hydrocephalus
    Track 5-7 Therapeutics of sleep disorders
    Track 6: Neurodegenerative Diseases and Neurorehabilitation
    Track 6-1 Alzheimer's disease
    Track 6-2 Parkinsonism
    Track 6-3 Down's syndrome
    Track 6-4 Schizophrenia
    Track 6-5 Autism
    Track 6-6 Migraine and headaches
    Track 6-7 Huntington disease
    Track 6-8 Movement disorders, neuromyopathy, and peripheral nerve disorder
    Track 7: Diagnostics in CNS disorders
    Track 7-1 Neuro imaging techniques
    Track 7-2 Diagnosis for cerebral infections
    Track 7-3 Genetic testing for neurological disorders
    Track 8: Therapeutics in Behavioral Neurology
    Track 8-1 Agnosias, aphasias and anosognosia
    Track 8-2 Amnesias and dementias
    Track 8-3 Traumatic brain injury and brain death
    Track 8-4 Attention deficit hyperactivity disorder (ADHD)
    Track 9: Neuroimmunology
    Track 9-1 Neural stem cells and neurosurgery
    Track 9-2 Neurodevelopmental diseases and thermogenesis
    Track 9-3 Neuroimmunological disorders
    Track 9-4 Neuro epidemiology
    Track 9-5 Neuromics, neuroproteomics, neurogenomics and human brain proteome
    Track 10: Pediatric neurology
    Track 10-1 Epilepsy in children, epilepsy prevention and management
    Track 10-2 Neurosurgery in epilepsy
    Track 10-3 Autistic children
    Track 10-4 Hydrocephalus in children
    Track 10-5 Krabbe disease
    Track 11: Current trends in Neurophysiology
    Track 11-1 Clinical neurophysiology and electrophysiology
    Track 11-2 Cerebral CSF flow studies
    Track 11-3 Electromyography, electroencephalography (EEG)
    Track 11-4 Evoked potentials
    Track 11-5 Polysomnography
    Track 12: Oncology of Central Nervous System
    Track 12-1 Innovative therapies for brain cancers
    Track 12-2 Chemotherapy for brain tumors
    Track 12-3 Radiation therapy for brain tumors
    Track 12-4 Pediatric neuro cancers
    Track 13: CNS Biomarkers
    Track 13-1 Supporting CNS drug development using biomarkers
    Track 13-2 Cerebral CSF flow studies
    Track 13-3 Cerebrospinal fluid biomarkers
    Track 13-4 Anti-amyloid therapies for Alzheimer's disease
    Track 13-5 Technology case studies for CNS
    Conference Secretariat: Central Nervous System-2012, OMICS Group Conferences
    5716 Corsa Ave., Suite 110, Westlake, Los Angeles, CA 91362-7354, USA
    Phone: +1-650-268-9744 l Fax: +1-650-618-1414
    Toll free: 1-800-216-6499(USA & Canada) | 1-800-651-097(Australia) | 0805-080048(Europe)
    Email: cns2012@omicsgroup.org
    Operated by: Editors - Journal of Drug Metabolism and Toxicology, Drug Designing: Open Access and Journal of Neurology and Neurophysiology
    The Organizers reserve the rights to make changes and adjustment to the information in this website
    Copyright 2008-2012 OMICS Group - All rights reserved
    Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version